u/genericasallfuck · 1966d agono track record yet
$CTXR – Citius will help save lives and lower healthcare costs while also making money – a win³. That's my prediction. Do the DD for yourself, of course.
Citius' Mino-Lok product addresses a real clinical need with limited competition and solid Phase 2 data, while management has significant personal investment in the company. The author expects strong upside from this pipeline as institutions adopt the stock and the company achieves commercial success.
At post $90.00live price unavailable
1d+2.5%
3d+2.5%
1w+9.4%
1m-46.4%
3m-43.6%
6m-53.9%
1y-75.5%